ATAGI 2024 Annual Statement on Immunisation
DOI:
https://doi.org/10.33321/cdi.2026.50.032Keywords:
immunisation, vaccine preventable diseases, AustraliaAbstract
The Australian Technical Advisory Group on Immunisation (ATAGI) 2024 Annual Statement on Immunisation is the fourth publication in this series. It highlights the key successes, trends and challenges in the use of vaccines and control of vaccine preventable diseases (VPDs) in Australia in 2023. It also signals ATAGI’s priority actions for addressing key issues for 2024 and beyond.
Downloads
References
Australian Government Department of Health, Disability and Ageing. Japanese encephalitis virus situation declared a Communicable Disease Incident of National Significance. [Media release.] Canberra: Australian Government Department of Health, Disability and Ageing; 4 March 2022. Available from: https://www.health.gov.au/news/japanese-encephalitis-virus-situation-declared-a-communicable-disease-incident-of-national-significance.
Australian Government Department of Health, Disability and Ageing. Statement on the end of Japanese encephalitis virus emergency response. [Media statement.] Canberra: Australian Government Department of Health, Disability and Ageing; 16 June 2023. Available from: https://www.health.gov.au/news/statement-on-the-end-of-japanese-encephalitis-virus-emergency-response.
Australian Government Department of Health, Disability and Ageing. Chief Medical Officer’s statement declaring monkeypox a Communicable Disease Incident of National Significance. [Media statement.] Canberra: Australian Government Department of Health, Disability and Ageing; 28 July 2022. Available from: https://www.health.gov.au/news/chief-medical-officers-statement-declaring-monkeypox-a-communicable-disease-incident-of-national-significance.
Australian Government Department of Health, Disability and Ageing. ATAGI Clinical Guidance on the use of vaccines for the prevention of Mpox. [Internet.] Canberra: Australian Government Department of Health, Disability and Ageing; 20 December 2024. Available from: https://www.health.gov.au/resources/publications/atagi-clinical-guidance-on-the-use-of-vaccines-for-the-prevention-of-mpox.
Australian Centre for Disease Control (Australian CDC). Mpox. [Internet.] Canberra: Australian CDC. Available from: https://www.cdc.gov.au/diseases/mpox.
Australian CDC. Mpox – CDNA National Guidelines for Public Health Units. Canberra: Australian CDC; 2025. Available from: https://www.cdc.gov.au/resources/publications/mpox-cdna-national-guidelines-public-health-units.
WHO. Statement following the Thirty-seventh Meeting of the International Health Regulations (IHR) Emergency Committee for Polio. [Media statement.] Geneva: WHO; 22 December 2023. Available from: https://www.who.int/news/item/22-12-2023-statement-following-the-thirty-seventh-meeting-of-the-ihr-emergency-committee-for-polio.
WHO. Statement of the Thirty-sixth Meeting of the Polio IHR Emergency Committee. [Media statement.] Geneva: WHO; 25 August 2023 [Available from: https://www.who.int/news/item/25-08-2023-statement-of-the-thirty-sixth-meeting-of-the-polio-ihr-emergency-committee.
Australian Government Department of Health, Disability and Ageing. Australian Immunisation Handbook: Measles. [Webpage.] Canberra: Australian Government Department of Health, Disability and Ageing; 23 October 2023. Available from: https://immunisationhandbook.health.gov.au/contents/vaccine-preventable-diseases/measles.
Australian Government Department of Health, Disability and Ageing, Therapeutic Goods Administration (TGA). COVID-19 vaccines regulatory status. [Internet.] Canberra: TGA; 27 May 2024. Available from: https://www.tga.gov.au/products/covid-19/covid-19-vaccines/covid-19-vaccines-regulatory-status.
Australian Government Department of Health, Disability and Ageing. End of COVID-19 emergency response. [Media statement.] Canberra: Australian Government Department of Health, Disability and Ageing; 20 October 2023. Available from: https://www.health.gov.au/news/end-of-covid-19-emergency-response.
Australian Government Department of Health, Disability and Ageing. National COVID-19 Health Management Plan for 2023. Canberra: Australian Government Department of Health, Disability and Ageing; 13 December 2022. Available from: https://www.health.gov.au/sites/default/files/2022-12/national-covid-19-health-management-plan-for-2023_0.pdf.
Australian Government Department of Health, Disability and Ageing. Coronavirus disease 2019 (COVID-19) epidemiology reports, Australia, 2022–2024. [Webpage.] Canberra: Australian Government Department of Health, Disability and Ageing; 23 April 2024. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/covid-19_epidemiology_reports_australia_2022-23.htm.
Australian Government Department of Health, Disability and Ageing. ATAGI Update on the COVID-19 Vaccination Program. [Internet.] Canberra: Australian Government Department of Health, Disability and Ageing; 1 September 2023. Available from: https://www.health.gov.au/news/atagi-update-on-the-covid-19-vaccination-program.
TGA. COVID-19 vaccine strain updates. [Internet.] Canberra: TGA; 6 September 2023. Available from: https://www.tga.gov.au/resources/resource/guidance/covid-19-vaccine-strain-updates.
Australian Government Department of Health, Disability and Ageing. COVID-19 vaccine rollout update – 12 January 2024. [Internet.] Canberra: Australian Government Department of Health, Disability and Ageing; 9 February 2024. Available from: https://www.health.gov.au/resources/publications/covid-19-vaccine-rollout-update-12-january-2024.
Australian Government Department of Health, Disability and Ageing. COVID-19 vaccination rollout update. [Internet.] Canberra: Australian Government Department of Health, Disability and Ageing; 12 December 2024. Available from: https://www.health.gov.au/resources/collections/covid-19-vaccination-rollout-update.
Australian Government Department of Health, Disability and Ageing. Australian Immunisation Handbook: COVID-19. [Webpage.] Canberra: Australian Government Department of Health, Disability and Ageing; 15 March 2024. Available from: https://immunisationhandbook.health.gov.au/contents/vaccine-preventable-diseases/covid-19#.
Australian Government Department of Health, Disability and Ageing. ATAGI 2023 booster advice. [Internet.] Canberra: Australian Government Department of Health, Disability and Ageing; 8 February 2023. Available from: https://webarchive.nla.gov.au/awa/20230212131450/https://www.health.gov.au/news/atagi-2023-booster-advice.
Australian Government Department of Health, Disability and Ageing. ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine. [Internet.] Canberra: Australian Government Department of Health, Disability and Ageing; 8 February 2023. Available from: https://www.health.gov.au/news/atagi-recommendations-on-use-of-the-pfizer-bivalent-originalomicron-ba45-covid-19-vaccine.
Australian Government Department of Health, Disability and Ageing. ATAGI recommendations on use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine. [Internet.] Canberra: Australian Government Department of Health, Disability and Ageing; 28 February 2023. Available from: https://www.health.gov.au/news/atagi-recommendations-on-use-of-the-moderna-bivalent-originalomicron-ba45-covid-19-vaccine.
Australian Government Department of Health, Disability and Ageing. ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older. [Internet.] Canberra: Australian Government Department of Health, Disability and Ageing; 30 May 2023. Available from: https://www.health.gov.au/news/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older.
Australian Government Department of Health, Disability and Ageing. ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines. [Internet.] Canberra: Australian Government Department of Health, Disability and Ageing; 20 November 2023. Available from: https://www.health.gov.au/news/atagi-recommendations-on-use-of-the-moderna-and-pfizer-monovalent-omicron-xbb15-covid-19-vaccines.
TGA. International Coalition of Medicines Regulatory Authorities (ICMRA) statement on the safety of COVID-19 vaccines. [Media release.] Canberra: TGA; 10 July 2023. Available from: https://www.tga.gov.au/news/media-releases/icmra-statement-safety-covid-19-vaccines.
Australian Government, Australian Institute of Health and Welfare (AIHW). Long COVID in Australia – a review of the literature. Canberra: AIHW; 16 December 2022. Available from: https://www.aihw.gov.au/reports/covid-19/long-covid-in-australia-a-review-of-the-literature/summary.
TGA. Articles – COVID-19 vaccine safety reports. [Webpage.] Canberra: TGA; 2 November 2023. [Not available online.]
AusVaxSafety. COVID-19 vaccines. [Webpage.] Sydney Children’s Hospital Network, NCIRS, AusVaxSafety; 18 March 2024. Available from: https://ausvaxsafety.org.au/vaccine-safety-data/covid-19-vaccines.
Australian Government Department of Health, Disability and Ageing. COVID-19 Vaccine Claims Scheme. [Internet.] Canberra: Australian Government Department of Health, Disability and Ageing; 19 December 2023. Available from: https://www.health.gov.au/our-work/covid-19-vaccine-claims-scheme.
Immunisation Coalition. Influenza Statistics. [Webpage.] Melbourne: Immunisation Coalition; 17 June 2024. Available from: https://www.immunisationcoalition.org.au/news-data/influenza-statistics/.
Australian Government Department of Health, Disability and Ageing. Australian Influenza Surveillance Report – 2023 End of Season Summary. Canberra: Australian Government Department of Health, Disability and Ageing; 21 December 2023. Available from: https://www.health.gov.au/sites/default/files/2023-12/aisr-2023-national-influenza-season-summary.pdf.
Archer BN, Chiu CK, Jayasinghe SH, Richmond PC, McVernon J, Lahra MM et al. Epidemiology of invasive meningococcal B disease in Australia, 1999–2015: priority populations for vaccination. Med J Aust. 2017;207(9):382–7. doi: https://doi.org/10.5694/mja16.01340.
George CR, Booy R, Nissen MD, Lahra MM. The decline of invasive meningococcal disease and influenza in the time of COVID-19: the silver linings of the pandemic playbook. Med J Aust. 2022;216(10):504–7. doi: https://doi.org/10.5694/mja2.51463.
Australian Government Department of Health, Disability and Ageing. Changes to HPV vaccine dose schedule for young Australians. [Internet.] Canberra: Australian Government Department of Health, Disability and Ageing; 6 February 2023. Available from: https://www.health.gov.au/news/changes-to-hpv-vaccine-dose-schedule-for-young-australians.
Australian Government Department of Health, Disability and Ageing. National Immunisation Program (NIP) changes from 1 July 2023. [Internet.] Canberra: Australian Government Department of Health, Disability and Ageing; 30 June 2023. Available from: https://www.health.gov.au/news/national-immunisation-program-nip-changes-from-1-july-2023.
Australian Government Department of Health, Disability and Ageing. National Immunisation Program – changes to shingles vaccination from 1 November 2023. [Internet.] Canberra: Australian Government Department of Health, Disability and Ageing; 8 October 2023. Available from: https://www.health.gov.au/news/national-immunisation-program-changes-to-shingles-vaccination-from-1-november-2023.
Queensland Government Department of Health (Queensland Health). Queensland MenB vaccination program. [Internet.] Brisbane: Queensland Health; 29 February 2024. Available from: https://www.health.qld.gov.au/clinical-practice/guidelines-procedures/diseases-infection/immunisation/meningococcal-b.
Government of South Australia Department of Health (SA Health). Meningococcal B Immunisation Program. [Media release.] Adelaide: SA Health; 6 July 2023. Available from: https://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/conditions/immunisation/immunisation+programs/meningococcal+b+immunisation+program.
SA Health. Meningococcal B program long-term protection. [Media release.] Adelaide: SA Health; 28 June 2023. Available from: https://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/about+us/news+and+media/all+media+releases/meningococcal+b+program+long-term+protection.
Wang B, Giles L, Andraweera P, McMillan M, Almond S, Beazley R et al. 4CMenB sustained vaccine effectiveness against invasive meningococcal B disease and gonorrhoea at three years post programme implementation. J Infect. 2023;87(2):95–102. doi: https://doi.org/10.1016/j.jinf.2023.05.021.
Government of Western Australia. Free flu vaccines extended for June 2023 to help WA stay well this winter. [Media release.] Perth: Government of Western Australia Department of the Premier and Cabinet; 5 July 2023. Available from: https://www.wa.gov.au/government/announcements/free-flu-vaccines-extended-june-2023-help-wa-stay-well-winter.
Pharmacy Guild of Australia. Queensland Government Free Influenza Vaccination Program. [Internet.] Canberra: Pharmacy Guild of Australia; 20 July 2023. Available from: https://www.guild.org.au/guild-branches/qld/professional-services/queensland-health-influenza-vaccination-program2.
Queensland Health. 2024 Free Flu Vaccination Program. [Internet.] Brisbane: Queensland Health; 30 April 2024. Available from: https://www.health.qld.gov.au/clinical-practice/guidelines-procedures/diseases-infection/immunisation/service-providers/2024-free-flu-vaccination-program.
NCIRS. Vaccination from community pharmacy – at a glance. [Online fact sheet.] Sydney Children’s Hospitals Network, NCIRS; April 2024. Available from: https://ncirs.org.au/fact-sheets-faqs/vaccines-from-community-pharmacy.
Hava C. Regulation changes allow more pharmacist-administered vaccines. [Online article.] Canberra: Pharmaceutical Society of Australia Ltd., Australian Pharmacist; 30 October 2023. Available from: https://www.australianpharmacist.com.au/regulation-changes-allow-more-pharmacist-administered-vaccines/.
Australian Government Department of Health, Disability and Ageing. Launch of the National Immunisation Program Vaccinations in Pharmacy (NIPVIP) Program. [Internet.] Canberra: Australian Government Department of Health, Disability and Ageing; 22 December 2023. Available from: https://www.health.gov.au/news/launch-of-the-national-immunisation-program-vaccinations-in-pharmacy-nipvip-program.
Yin JK, Heywood AE, Georgousakis M, King C, Chiu C, Isaacs D et al. Systematic review and meta-analysis of indirect protection afforded by vaccinating children against seasonal influenza: implications for policy. Clin Infect Dis. 2017;65(5):719–28. doi: https://doi.org/10.1093/cid/cix420.
National Centre for Immunisation Research and Surveillance (NCIRS). Vaccination coverage in children continues to decline following easing of pandemic-related restrictions. [Media release.] Sydney Children’s Hospitals Network, NCIRS; January 2024. Available from: https://ncirs.org.au/vaccination-coverage-children-continues-decline-following-easing-pandemic-related-restrictions.
TGA. Arexvy Australian Prescription Medicine Decision Summary. [Internet.] Canberra: TGA; 22 January 2024. Available from: https://www.tga.gov.au/resources/auspmd/arexvy.
TGA. Abrysvo (RSV vaccine) Australian Prescription Medicine Decision Summary. [Internet.] Canberra: TGA; 22 May 2024. Available from: https://www.tga.gov.au/resources/auspmd/abrysvo.
TGA. MRESVIA Moderna Australia Pty Ltd. [Internet.] Canberra: TGA; 28 March 2025. Available from: https://www.tga.gov.au/resources/prescription-medicines-registrations/mresvia-moderna-australia-pty-ltd.
Australian Government Department of Health, Disability and Ageing. ATAGI statement on the clinical use of Arexvy (RSV PRE-F3) vaccine for RSV. [Online fact sheet.] Canberra: Australian Government Department of Health, Disability and Ageing; 30 April 2024. Available from: https://www.health.gov.au/resources/publications/atagi-statement-on-the-clinical-use-of-arexvy-rsv-pre-f3-vaccine-for-rsv.
TGA. Report a problem or side effect. [Webpage.] Canberra: TGA; Available from: https://www.tga.gov.au/safety/reporting-problems.
AusVaxSafety. Influenza vaccines. [Webpage.] Sydney Children’s Hospital Network, NCIRS, AusVaxSafety; 2024. Available from: https://ausvaxsafety.org.au/safety-data/influenza-vaccine.
AusVaxSafety. Mpox (monkeypox) vaccine. [Webpage.] Sydney Children’s Hospital Network, NCIRS, AusVaxSafety; 17 April 2023. Available from: https://ausvaxsafety.org.au/vaccine-safety-data/mpox-monkeypox-vaccine.
Deng L, Lopez LK, Glover C, Cashman P, Reynolds R, Macartney K et al. Short-term adverse events following immunization with modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine for Mpox. JAMA. 2023;329(23):2091–4. doi: https://doi.org/10.1001/jama.2023.7683.
Australian Government Department of Health, Disability and Ageing. Mpox (monkeypox) vaccines. [Internet.] Canberra: Australian Government Department of Health, Disability and Ageing; 1 August 2024. Available from: https://www.health.gov.au/diseases/mpox-monkeypox/vaccines.
United States Centers for Disease Control and Prevention (US CDC). Vaccine Safety: Mpox Vaccines. [Internet.] Atlanta: United States Government Department of Health & Human Services, CDC; 30 January 2024. Available from: https://www.cdc.gov/vaccinesafety/vaccines/Monkeypox-Vaccine.html.
AusVaxSafety. Shingrix®. [Webpage.] Sydney: Sydney Children’s Hospital Network, NCIRS, AusVaxSafety; 20 December 2023. Available from: https://www.ausvaxsafety.org.au/shingrixr-vaccine-safety-data-now-available.
TGA. Live vaccines – what are the contraindications? [Internet.] Canberra: TGA; 4 May 2023. Available from: https://www.tga.gov.au/news/safety-updates/live-vaccines-what-are-contraindications.
World Health Organization (WHO). Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: WHO; 17 November 2020. Available from: https://www.who.int/publications/i/item/9789240014107.
Australian Government Department of Health, Disability and Ageing. Australian Technical Advisory Group on Immunisation (ATAGI) strategic intent. Canberra: Australian Government Department of Health, Disability and Ageing; 10 September 2020. Available from: https://www.health.gov.au/sites/default/files/documents/2020/09/atagi-strategic-intent.pdf.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
